Biocon Limited has submitted a regulatory filing pursuant to Regulation 30(6) of the SEBI Listing Regulations to intimate its schedule of meetings with analysts and institutional investors.
The management of the company is scheduled to meet with analysts and institutional investors at the Motilal Oswal 22nd Annual Global Investor Conference. The meeting is scheduled for August 17, 2026, in Mumbai. The type of interaction will be 1x1 meetings, group meetings, or in-person meetings.
The company explicitly states that it will not disclose any Unpublished Price Sensitive Information (UPSI) during these meetings. The disclosure also notes that the schedule is subject to change due to exigencies on the part of investors or the company.
The above information will also be made available on the company's website at www.biocon.com.
The letter is signed by Rajesh Umakant Shanoy, Company Secretary and Compliance Officer (Membership No.: ACS 16328), on behalf of Biocon Limited.